trial

Do Self-Report and Physician Impressions of Adherence to Oral Antipsychotic Medication Agree With Objective Data?

NCTId NCT00223522
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 50
Sponsored by The University of Texas Health Science Center at San Antonio
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
50
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2004-04
Primary completion
—
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
MEMS caps

Sponsors

The University of Texas Health Science Center at San AntonioLead Sponsor
Janssen, L.P. - Investigator Initiated Studies ProgramCollaborator

Investigators

1
Dawn' I Velligan, Ph.D.Principal Investigator

Sites

1 total
San Antonio, United States

Facts & assertions

3 sourced
Enrollment
50
Phase
NA
Status
COMPLETED
relationships
The graph out of here
drug
MEMS caps
drug
lead_sponsor
The University of Texas Health Science Center at San Antonio
company
collaborator
Janssen, L.P. - Investigator Initiated Studies Program
company
indication
Schizophrenia
indication
Schizoaffective
indication
Schizophrenia
indication
investigator
Dawn' I Velligan, Ph.D.
person